| 26/448 |
Maternity Complaints 2015-2025 |
| 26/412 |
Spend |
| 26/386 |
Agency Spend |
| 26/385 |
Nasogastric Tubes |
| 26/384 |
Enhanced Therapeutic Observation and Care (ETOC) Policy |
| 26/383 |
Maternity |
| 26/382 |
Management of Monogenic Diabetes in Pregnancy |
| 26/380 |
Staff Log-ins from Overseas during 2025-26 |
| 26/378 |
Biologics Medicines in Gastroenterology |
| 26/377 |
Memory Assessment Service Staffing (WTE) |
| 26/375 |
Paracetamol Overdose Presentations 2024/25 |
| 26/374 |
Managed Print Services |
| 26/372 |
Omega-3 Supplementation in Pregnancy |
| 26/368 |
Immunoglobulin |
| 26/367 |
Admissions by GP Practice |
| 26/366 |
Number of Asbestos-related Illness Referrals in under 21s |
| 26/365 |
Counter Fraud |
| 26/364 |
Agency Spend |
| 26/363 |
EUCAST Antimicrobial Susceptibility Testing |
| 26/362 |
Specialist Continuity / High-Risk Maternity Teams |
